Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Recombinant Cell Culture Supplements Market 2018-2028: Focus on Recombinant Supplement Products, Applications and Region - ResearchAndMarkets.com

Research and Markets
Posted on: 13 Dec 18

The "Global Recombinant Cell Culture Supplements Market: Focus on Recombinant Supplement Products, Applications, and Region - Analysis and Forecast: 2018 to 2028" report has been added to ResearchAndMarkets.com's offering.

The global recombinant cell culture supplements market was valued $230.5 million in 2017 and is anticipated to reach $788.6 million by 2028.

The market is expected to grow due to the benefits of recombinant supplements over normal animal-derived supplements. Recombinant cell culture supplements are purer than animal-derived supplements in terms of consistency and safety profile. They are also cheaper and require less raw materials to form a complete cell culture media as compared to their animal counterparts. Other factors supporting the growth of the market include increasing investment in the R&D of life sciences and biotechnology industries.

Based on applications, the market can be sub-segmented into stem cell and regenerative medicine, bioproduction, and academic and research. In 2017, stem cell and regenerative medicine was estimated to be the dominant application segment. However, the academic and research industry is expected to register the highest CAGR.

Based on types, the recombinant albumin was the dominant segment in terms of revenue in 2017 while recombinant epidermal growth factor (rEGF) segment is expected to be the fastest growing segment during the forecast period from 2018 to 2028.

Market Dynamics

Drivers

  • Benefits of Using Recombinant Cell Culture Supplements
  • Increase in Funding and Investment in R&D of Life Science Sector
  • Rising Demand for Advanced Cell Culture Products

Restraints

  • High Cost of Cell Biology Research
  • Technical Considerations Associated with Cell Culture
  • Lack of Infrastructure and Skilled Professionals for Cell-based Research

Opportunities

  • Rising Demand for Monoclonal Antibodies and Stem Cell Research
  • Increasing Preference for Serum-Free Media

Key Topics Covered


Executive Summary

1 Market Overview

2 Market Dynamics

3 Industry Insights

4 Competitive Landscape

5 Global Recombinant Cell Culture Supplements Market (by Products)

6 Global Recombinant Cell Culture Supplements Market (by Application)

7 Global Recombinant Cell Culture Supplements Market (by Region)

8 Company Profiles

  • Albumedix
  • BBI Solutions
  • Corning Incorporated
  • Evercyte GmbH
  • Gemini Bio-Products
  • HiMedia Laboratories
  • InVitria
  • Irvine Scientific
  • Kingfisher Biotech Inc.
  • Lonza Group
  • Merck KGaA
  • Novozymes
  • PeproTech Inc.
  • Repligen Corporation
  • STEMCELL Technologies Inc.
  • Shenandoah Biotechnology
  • Sino Biological Inc.
  • Thermo Fisher Scientific

For more information about this report visit https://www.researchandmarkets.com/research/nr868c/global?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181213005403/en/

Business Wire
www.businesswire.com

Last updated on: 13/12/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.